Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00537134 · ClinicalTrials.gov registry record · NA
Trial on Endovascular Aneurysm Management
A NA study, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- Terminated
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00537134: Clinical Trial NA study, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
NCT00537134 is a NA study that was terminated before completion, run by Centre hospitalier de l'Université de Montréal (CHUM). The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00537134, a NA study, was terminated before completion, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- TERMINATED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The management of patients with unruptured aneurysms is controversial. Patients with unruptured aneurysms may suffer intracranial hemorrhage, but the incidence of this event is still debated. Endovascular treatment can prevent rupture, but involves immediate risks; furthermore, successful treatment does not eliminate all risks. A randomized trial may be the best way to demonstrate the potential benefits of endovascular over conservative management of unruptured aneurysms.
Primary Outcome
Morbidity or mortality is evaluated using the modified Rankin Scale (mRS) which goes from 0 to 6, with 0 for no symptoms at all, and 6 for Mortality. The scores were attributed using a structured interview process. a "Good" Primary Outcome was categorized from mRS scores of 0, 1, or 2. a "Bad" Primary Outcome was categorized from mRS scores of 3, 4, 5 or 6.
Interventions
- DEVICE Embolization, coiling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-07 |
| Phase | NA |
Why NCT00537134 stopped before completion
NCT00537134 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Embolization, coiling is the first listed.
NCT00537134 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00537134 about?
NCT00537134 is a clinical study titled "Trial on Endovascular Aneurysm Management". The management of patients with unruptured aneurysms is controversial. Patients with unruptured aneurysms may suffer intracranial hemorrhage, but the incidence of this event is still debated. Endovascular treatment can prevent rupture, but involves immediate risks; furthermore, successful treatment ...
What is the current status of trial NCT00537134?
This trial is currently terminated. It is a NA study. The enrollment target is 80 participants. The study started on 2006-04. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00537134?
The interventions under investigation include: Embolization, coiling (DEVICE).
Who is sponsoring clinical trial NCT00537134?
This trial is sponsored by Centre hospitalier de l'Université de Montréal (CHUM), which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00537134's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia